Serum Hsa_circ_0007534 As a Diagnostic Biomarker for Ovarian Cancer

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2024 Nov 15

PMID 39544800

Authors

Mingyue Cao

Yunchao Gu

Beidi Lv

Shouqian Liu

Yuanming Shen

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the implications of serum hsa_circ_0007534 levels in ovarian cancer (OC) patients.

Methods: A retrospective analysis was conducted on the clinical data of 102 OC patients, and 102 healthy controls (HCs) were included in this study. Serum levels of hsa_circ_0007534 were measured using qPCR. The relationship between circRNA levels and clinicopathologic characteristics was analyzed. Additionally, the diagnostic performances of serum hsa_circ_0007534 and CA-125 levels in OC patients were evaluated using Receiver Operating Characteristic (ROC) curve analyses.

Results: OC patients had significantly elevated serum hsa_circ_0007534 levels compared to HCs, allowing a differentiation between OC patients and HCs. Higher serum hsa_circ_0007534 levels were associated with more aggressive disease features and poorer overall survival. Patients with elevated hsa_circ_0007534 levels tended to have worse clinical outcome compared to those with lower levels. Multivariate analyses indicated that high hsa_circ_0007534 levels were independently associated with poorer outcome. Furthermore, serum hsa_circ_0007534 levels effectively distinguished between chemoresistant and chemosensitive patient groups.

Conclusions: Serum hsa_circ_0007534 levels may serve as valuable predictors of prognosis in OC patients.

References

Zhang W, He Y, Zhang Y . CircRNA in ocular neovascular diseases: Fundamental mechanism and clinical potential. Pharmacol Res. 2023; 197:106946. DOI: 10.1016/j.phrs.2023.106946. View

Zhang M, Sun Y, Xu H, Shi Y, Shen R, Teng F . Circular RNA hsa_circ_0007444 inhibits ovarian cancer progression through miR-23a-3p/DICER1 axis. Acta Biochim Biophys Sin (Shanghai). 2023; 55(4):574-586. PMC: 10195148. DOI: 10.3724/abbs.2023052. View

Sun Y, Liu Y, Chen H, Tan Y . Circular RNA circRHOBTB3 inhibits ovarian cancer progression through PI3K/AKT signaling pathway. Panminerva Med. 2020; 66(1):36-46. DOI: 10.23736/S0031-0808.20.03957-9. View

Wei G, Zhu J, Hu H, Liu J . Circular RNAs: Promising biomarkers for cancer diagnosis and prognosis. Gene. 2020; 771:145365. DOI: 10.1016/j.gene.2020.145365. View

Li G, Li L, Yao Z, Zhuang S . Hsa_circ_0007534/miR-761/ZIC5 regulatory loop modulates the proliferation and migration of glioma cells. Biochem Biophys Res Commun. 2018; 499(4):765-771. DOI: 10.1016/j.bbrc.2018.03.219. View

Wu D, Liu J, Yu L, Wu S, Qiu X . Circular RNA hsa_circ_0000144 aggravates ovarian Cancer progression by regulating ELK3 via sponging miR-610. J Ovarian Res. 2022; 15(1):113. PMC: 9569040. DOI: 10.1186/s13048-022-01048-3. View

Liu S, Yuan L, Li J, Liu Y, Wang H, Ren X . circDENND4C, a novel serum marker for epithelial ovarian cancer, acts as a tumor suppressor by downregulating miR-200b/c. Ann Med. 2023; 55(1):908-919. PMC: 10795628. DOI: 10.1080/07853890.2023.2185289. View

Song L, Xiao Y . Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway. Biochem Biophys Res Commun. 2018; 503(4):2603-2610. DOI: 10.1016/j.bbrc.2018.08.007. View

Wang X, Yao Y, Jin M . Circ-0001068 is a novel biomarker for ovarian cancer and inducer of PD1 expression in T cells. Aging (Albany NY). 2020; 12(19):19095-19106. PMC: 7732319. DOI: 10.18632/aging.103706. View

10.

Sheng R, Li X, Wang Z, Wang X . Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer. Cancer Lett. 2020; 473:139-147. DOI: 10.1016/j.canlet.2019.12.043. View

11.

Park Y, Lee J, Hong D, Lee E, Kim H . Diagnostic performances of HE4 and CA125 for the detection of ovarian cancer from patients with various gynecologic and non-gynecologic diseases. Clin Biochem. 2011; 44(10-11):884-8. DOI: 10.1016/j.clinbiochem.2011.04.011. View

12.

Zhang W, Yang S, Liu Y, Wang Y, Lin T, Li Y . Hsa_circ_0007534 as a blood-based marker for the diagnosis of colorectal cancer and its prognostic value. Int J Clin Exp Pathol. 2020; 11(3):1399-1406. PMC: 6958175. View

13.

Rong X, Gao W, Yang X, Guo J . Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling. Life Sci. 2019; 235:116785. DOI: 10.1016/j.lfs.2019.116785. View

14.

Wu M, Qiu Q, Zhou Q, Li J, Yang J, Zheng C . circFBXO7/miR-96-5p/MTSS1 axis is an important regulator in the Wnt signaling pathway in ovarian cancer. Mol Cancer. 2022; 21(1):137. PMC: 9241180. DOI: 10.1186/s12943-022-01611-y. View

15.

Lu K . Screening for Ovarian Cancer in Asymptomatic Women. JAMA. 2018; 319(6):557-558. DOI: 10.1001/jama.2017.21894. View

16.

Shi Y, He R, Yang Y, He Y, Shao K, Zhan L . Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review). Oncol Rep. 2020; 44(5):1787-1798. PMC: 7551080. DOI: 10.3892/or.2020.7780. View

17.

Wang G, Zhang H, Li P . Upregulation of hsa_circRNA_102958 Indicates Poor Prognosis and Promotes Ovarian Cancer Progression Through miR-1205/SH2D3A Axis. Cancer Manag Res. 2020; 12:4045-4053. PMC: 7264029. DOI: 10.2147/CMAR.S248560. View

18.

Wang S, Zhang K, Tan S, Xin J, Yuan Q, Xu H . Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies. Mol Cancer. 2021; 20(1):13. PMC: 7798340. DOI: 10.1186/s12943-020-01298-z. View

19.

Ning L, Lang J, Wu L . Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer. BMC Cancer. 2022; 22(1):6. PMC: 8721970. DOI: 10.1186/s12885-021-09073-z. View

20.

Pan Y, Huang Q, Peng X, Yu S, Liu N . Circ_0015756 promotes ovarian cancer progression via the miR-145-5p/PSAT1 axis. Reprod Biol. 2022; 22(4):100702. DOI: 10.1016/j.repbio.2022.100702. View